Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 447,229 | 279,659 | 157,024 | 35,538 | 3,377 |
| Gross Profit | 447,229 | 279,659 | 157,024 | 35,538 | 3,377 |
| Operating Expenses | 655,861 | 462,512 | 350,966 | 52,565 | 26,274 |
| Operating Income | -208,632 | -182,853 | -193,942 | -17,027 | -22,897 |
| Interest Expense | 4,839 | 3,879 | 4,460 | 3,403 | 3,403 |
| Other Income | -6,231 | 9,168 | 1,092 | 2,909 | 436 |
| Pre-tax Income | -219,702 | -177,564 | -197,310 | -17,521 | -25,864 |
| Income Tax | 3,017 | N/A | 0 | N/A | 0 |
| Net Income Continuous | -222,719 | -177,564 | -197,310 | -17,521 | -25,864 |
| Net Income | $-222,719 | $-177,564 | $-197,310 | $-17,521 | $-25,864 |
| EPS Basic Total Ops | -3.05 | -3.18 | -3.21 | -0.30 | -0.58 |
| EPS Basic Continuous Ops | -3.05 | -3.18 | -3.21 | -0.30 | -0.58 |
| EPS Diluted Total Ops | -3.05 | -3.18 | -3.21 | -0.30 | -0.58 |
| EPS Diluted Continuous Ops | -3.05 | -3.18 | -3.21 | -0.30 | -0.58 |
| EBITDA(a) | $-206,315 | $-181,059 | $-192,756 | $-16,047 | $-21,972 |